## Abstract A nonaromatic, small‐molecule, gadolinium(3+)‐chelate code named MP‐2269 was synthesized and evaluated in animals as a potential MR contrast agent for blood pool. The ligand of MP‐2269 was prepared by conjugating a lipophilic, albumin‐binding moiety, 4‐pentylbicyclo[2.2.2]octane‐1‐carbo
Development of a novel nonaromatic small-molecule MR contrast agent for the blood pool
✍ Scribed by Adzamli, Kofi; Haar, Joseph P.; Hynes, Michael R.; Miller, Donald B.; Polta, John A.; Wallace, Rebecca A.; Woulfe, Steven R.; Adams, Max D.
- Book ID
- 123347963
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 304 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1076-6332
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To design an ideal first‐pass profile for MR angiography (MRA) by optimizing a multiphasic injection protocol based on two experimental animal models. ## Materials and Methods An equivalent contrast‐enhanced (CE) MRA injection protocol was developed with controlled injecti
## Abstract The purpose of this study was to determine the value of a blood‐pool contrast media (NC100150, Nycomed Imaging (now Amersham Health) Oslo, Norway) for evaluation of venous thrombosis of the deep veins of the pelvis and lower extremities. Twelve patients were prospectively evaluated with